| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/01/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/28/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/23/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/22/2022 |
8-K
| Resignation/termination of a director |
| 03/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/21/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/21/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/11/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/11/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/09/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/04/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/04/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/24/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/24/2022 |
SC 13G
| Versor Investments LP reports a 5.1% stake in BioDelivery Sciences International, Inc. |
| 02/18/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/18/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 02/18/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 02/15/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/15/2022 |
8-K/A
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulat... |
| 02/14/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/14/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/14/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 02/14/2022 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulat... |
| 02/14/2022 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 0% stake in BioDelivery Sciences International, Inc. |
| 02/14/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 11/03/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/03/2021 |
8-K
| Quarterly results |
| 10/21/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/27/2021 |
8-K
| Quarterly results |
|